alogliptin benzoate/pioglitazone HCl

12.5 mg-30 mg, 25 mg-15 mg, 25 mg-30 mg, 25 mg-45 mg — Tablet

DIABETES NON-INSULIN

Also known as: OSENI ALOGLIPTIN-PIOGLITAZONE

Coverage by Insurer

Informational only — Coverage rules change frequently; verify tier placement and restrictions with your plan or pharmacy before acting.
Source: PDF  ·  Formulary date: Apr 1, 2026  ·  Checked: 14 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
BCBS Federal Standard Option 2026
via alogliptin-pioglitazone
Tier 1 - Generic None
BCBS Federal Basic Option 2026
via alogliptin-pioglitazone
Tier 1 - Generic None
BCBS Federal Focus 2026
via alogliptin-pioglitazone
Tier 1 - Generic None
Source: PDF  ·  Formulary date: Apr 1, 2026  ·  Checked: 14 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
NC Medicaid Preferred Drug List 2026
via alogliptin-pioglitazone
Non-Preferred None
NC Medicaid Preferred Drug List 2026
via Oseni
Non-Preferred None
Source: PDF  ·  Formulary date: Apr 1, 2026  ·  Checked: 14 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
NC State Health Plan - 80/20 Plus PPO 2026
via alogliptin-pioglitazone
Not Covered None
NC State Health Plan - 70/30 Standard PPO 2026
via alogliptin-pioglitazone
Not Covered None
NC State Health Plan - HDHP 2026
via alogliptin-pioglitazone
Not Covered None
Source: Excel (XLSX)  ·  Formulary date: Jan 5, 2026  ·  Checked: 14 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
TRICARE Uniform Formulary 2026 Tier 3 - Non-Formulary PA
Something not right?